Hacettepe University Medical School is a medical school located at Hacettepe University Medical Center in Ankara, Turkey.

During the past decade, Hacettepe Universitesi Tip Fakultesi Hastanesi conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 9 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 8 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hacettepe Universitesi Tip Fakultesi Hastanesi" #1 sponsor was "Incyte Corporation" with 4 trials, followed by "Celgene" with 2 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored, "Takeda" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hacettepe Universitesi Tip Fakultesi Hastanesi" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator and "Zai Lab (Shanghai) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hacettepe Universitesi Tip Fakultesi Hastanesi" are "Multiple Myeloma" (2 trials), "Autologous Stem Cell Transplant" (1 trials), "Complicated Intra-Abdominal Infection" (1 trials), "Complicated Urinary Tract Infection" (1 trials) and "Follicular Lymphoma" (1 trials). Many other conditions were trialed in "Hacettepe Universitesi Tip Fakultesi Hastanesi" in a lesser frequency.

Most popular intervention types in "Hacettepe Universitesi Tip Fakultesi Hastanesi" are "Drug" (10 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Carboplatin" (2 trials), "Ceftolozane/Tazobactam" (2 trials), "Cisplatin" (2 trials) and "Epacadostat" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hacettepe Universitesi Tip Fakultesi Hastanesi" are 11 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hacettepe Universitesi Tip Fakultesi Hastanesi". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hacettepe Universitesi Tip Fakultesi Hastanesi, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hacettepe Universitesi Tip Fakultesi Hastanesi, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".